Curaleaf Holdings, Inc.
corporate_fare Company Profile
Curaleaf Holdings, Inc. (OTC:CURLF) is a publicly traded company in the Life Sciences sector. Wiseek monitors CURLF SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Curaleaf Announces 1-for-3 Reverse Stock Split to Enable U.S. Exchange Uplisting
- Curaleaf Proposes Dual-Class Share Entrenchment, Option Repricing, and Delaware Re-domiciliation
- Curaleaf Reports Strong Q1 Profit Driven by $97M Tax Benefit from DEA Rescheduling
- Curaleaf to Vote on CEO Control, Insider Option Repricing, and Delaware Re-domiciliation
- Curaleaf Appoints Four 20 Pharma Founder Torsten Greif to Board, Bolstering European Strategy
Financial Snapshot
Insider Transactions
CURLF files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.